An economic evaluation of screening for Chlamydia trachomatis in adolescent males.

OBJECTIVE To assess the cost-effectiveness of identifying asymptomatic carriers of Chlamydia trachomatis among adolescent males. DESIGN Cost-effectiveness analysis based on cohort analytic studies previously reported and average salaries and costs of medical care in Sweden. SETTING Adolescent males attending a primary care center for routine health checks. PARTICIPANTS Estimates of costs and benefits are based on a cohort of 1000 adolescent males and their female contacts. INTERVENTION Screening with enzyme immunoassay (EIA), either on leukocyte esterase (LE)--positive urine samples (LE-EIA screening) or on all urine samples (EIA screening), was compared with no screening (no treatment or contact tracing). The effects of confirming positive EIA results with a blocking assay and alternative antibiotic regimens on the outcome of the screening strategies were also evaluated. RESULTS Compared with no screening, the LE-EIA and EIA screening strategies reduced the overall costs when the prevalence of chlamydial infection in males exceeded 2% and 10%, respectively. Enzyme immunoassay screening achieved an overall cure rate that was 12.2% to 12.6% (95% confidence interval) better, but reduced the incremental savings by at least $2144 per cured male, in comparison with LE-EIA screening. Confirmation of positive EIA results reduced the overall cost of the LE-EIA screening strategy when the prevalence of C trachomatis among males was less than 8%. Compared with a 7-day course of doxycycline, a single oral dose of azithromycin administered under supervision in the clinic improved the cure rates of both EIA and LE-EIA screening strategies by 15.1% to 16.3% and 11.2% to 12.0%, respectively, while reducing the corresponding overall costs by 5% and 9%, respectively, regardless of the prevalence of chlamydial infection in males. CONCLUSION The use of LE-EIA screening combined with treatment of positive cases with azithromycin was the most cost-effective intervention strategy focusing on asymptomatic male carriers of C trachomatis. Positive EIA results should be confirmed when screening low-risk populations.

[1]  L. Pickard,et al.  Rapid, on-site diagnosis of chlamydial urethritis in men by detection of antigens in urethral swabs and urine , 1991, Journal of clinical microbiology.

[2]  G. Mumtaz,et al.  Azithromycin vs Doxycycline in the Treatment of Non-Gonococcal Urethritis , 1991, International journal of STD & AIDS.

[3]  L Weström,et al.  Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. , 1980, American journal of obstetrics and gynecology.

[4]  M. Aronson,et al.  Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. , 1987, Annals of internal medicine.

[5]  T. Bell,et al.  Use of a leukocyte esterase dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees. , 1988, American journal of public health.

[6]  M. Nettleman,et al.  Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. , 1988, JAMA.

[7]  A. Medeiros,et al.  Diagnosis of gonorrhea in male patients by culture of uncentrifuged first-voided urine. , 1977, JAMA.

[8]  J. Goddeeris,et al.  Benefit-Cost Analysis of Screening: A Comparison of Tests for Gonorrhea , 1985, Medical care.

[9]  L. Forsman,et al.  Screening for asymptomatic Chlamydia trachomatis infection in adolescent men by examination of voided urine. , 1992, Genitourinary medicine.

[10]  Robert B. Jones,et al.  A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis , 1992 .

[11]  J. Sellors,et al.  Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and cultures. , 1990, The Journal of infectious diseases.

[12]  A. Randolph,et al.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis. , 1990, American journal of public health.

[13]  J. Cruz,et al.  Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males , 1992, Journal of clinical microbiology.

[14]  A. Washington,et al.  A Cost-Based Decision Analysis for Chlamydia Screening in California Family Planning Clinics , 1988, Obstetrics and gynecology.

[15]  C. Begley,et al.  The Incremental Cost of Screening, Diagnosis, and Treatment of Gonorrhea and Chlamydia in a Family Planning Clinic , 1989, Sexually transmitted diseases.

[16]  A. Washington,et al.  Chlamydia trachomatis infections in the United States. What are they costing us? , 1987, JAMA.

[17]  A. Washington,et al.  The economic cost of pelvic inflammatory disease. , 1986, JAMA.

[18]  B. Backe,et al.  Cost Effectiveness of Testing for Chlamydial Infections in Asymptomatic Women , 1989, Medical care.

[19]  S. Emans,et al.  First catch urine sediment for Chlamydia trachomatis and Neisseria gonorrhoeae culture in adolescent males with pyuria. , 1991, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[20]  W. Pittard,et al.  Gonorrhea detection by urine sediment culture. , 1973, JAMA.

[21]  S. Morse,et al.  Gonococcal Urethritis Diagnosed from Enzyme Immunoassay of Urine Sediment , 1988, Sexually transmitted diseases.

[22]  A. Johansson,et al.  A Retrospective Study of Efforts to Diagnose Infections by Chlamydia trachomatis in a Swedish County , 1991, Sexually transmitted diseases.

[23]  M. Genç,et al.  Detection of Chlamydia trachomatis antigens in first‐void urine to identify asymptomatic male carriers , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  S. Emans,et al.  Dipstick leukocyte esterase activity in first-catch urine specimens. A useful screening test for detecting sexually transmitted disease in the adolescent male. , 1987, JAMA.

[25]  A. Moscicki,et al.  Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. , 1989, JAMA.

[26]  B. Katz,et al.  Efficiency and Cost‐effectiveness of Field Follow‐up for Patients with Chlamydia trachomatis lnfection in a Sexually Transmitted Diseases Clinic , 1988, Sexually transmitted diseases.

[27]  J Schachter,et al.  Experience with the routine use of erythromycin for chlamydial infections in pregnancy. , 1986, The New England journal of medicine.

[28]  P. Wölner‐Hanssen,et al.  Pathogenesis of pelvic inflammatory disease. , 1993, Genitourinary medicine.

[29]  Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. , 1993, American journal of obstetrics and gynecology.

[30]  P. Mårdh,et al.  Chlamydial and gonococcal infections in a defined population of women. , 1982, Scandinavian journal of infectious diseases. Supplementum.

[31]  B. Thomas,et al.  Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis. , 1991, Journal of clinical pathology.

[32]  Judson Fn.  Assessing the number of genital chlamydial infections in the United States. , 1985 .

[33]  Ana Estany,et al.  Early Detection of Genital Chlamydial Infection in Women: An Economic Evaluation , 1989, Sexually transmitted diseases.